Milestone Pharmaceuticals Inc.
MIST | NASDAQ
$0.92
$0 (+0.24%)
Sep 22, 2026, 9:43 AM ET · Market open
Market Data
Market Cap $114.26M
Enterprise Value $3.72M
Beta 0.98
Average Volume 1.42M
Shares Outstanding (Diluted) 138.69M
Shares Change YoY 108.94%
Institutional Ownership 30.34%
Exchange NASDAQ
ISIN CA59935V1076
Price Performance
Price Change 1M -12.4%
Price Change 3M -29.2%
Price Change 6M -26.4%
Price Change YTD -55.1%
Price Change 1Y -54.2%
Price Change 3Y -69.3%
Price Change 5Y -83.6%
1M CAGR (ann.) -24.8%
1Y CAGR (ann.) -52.9%
5Y CAGR (ann.) -30.5%
All-Time CAGR -31.8%
Valuation
PE Ratio -1.33
Forward PE N/A
PEG Ratio -0.07
Forward PEG 1.31
PS Ratio 48.77
Forward PS 5.20
PB Ratio 6.27
P/FCF Ratio -2.96
P/Adj. FCF Ratio -2.45
P/OCF Ratio -2.09
EV/Sales 1.59
EV/EBIT -0.05
EV/EBITDA -0.05
EV/FCF -0.10
Earnings Yield -75.0%
FCF Yield -33.8%
Adj. FCF Yield -40.8%
Financial Health
Net Cash $111.4M
Total Debt $60.07M
Cash & Short-Term Investments $170.61M
Total Assets $181.63M
Current Ratio 8.13
Quick Ratio 7.92
Debt / Equity Ratio 7.79
Debt / EBITDA -0.82
Debt / FCF -1.55
OCF / Debt -0.64
Interest Coverage -7.27
Altman Z-Score -3.60
Piotroski F-Score 5
Margins & Profitability
Gross Profit Margin 94.6%
Operating Profit Margin -3353.0%
EBITDA Margin -3124.6%
Net Profit Margin -3585.6%
FCF Margin -1649.9%
Adj. FCF Margin -1990.0%
SBC / Revenue 340.1%
SBC Impact (per share) -20.6%
Returns
Return on Assets -46.3%
Return on Equity -288.4%
Return on Invested Capital -49.0%
Return on Capital Employed -49.3%
Return on Tangible Assets -46.3%
Historical Growth (CAGR)
Revenue CAGR 3Y -26.9%
Revenue CAGR 5Y -31.0%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 23.8%
EPS CAGR 5Y 18.7%
EPS CAGR 10Y N/A
FCF CAGR 3Y -2.1%
FCF CAGR 5Y 7.2%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 7
EPS Growth Next 3Y 36.2%
Revenue Growth Next 3Y 329.4%
Earnings Date Nov 10, 2026
EPS Estimate (next Q) -$0.20
EPS Growth Est (next Q) 66.7%
Revenue Est (next Q) $1.14M
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $4.50
Price Target Upside 389.1%
Cash Flow
Operating Cash Flow $-38.64M
Free Cash Flow $-38.66M
Adj. Free Cash Flow $-46.62M
FCF Per Share -$0.44
OCF Per Share -$0.44
OCF/S Ratio -2611.1%
Income Statement
Revenue $2.34M
Gross Profit $2.22M
Operating Income $-78.56M
EBITDA $-73.21M
Net Income $-84.01M
EPS (Diluted) -$0.69
Revenue / Employee $61.66K
Profit / Employee $-2.21M
Employees 38
Add to Watchlist
Select watchlists to add or remove MIST